Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-06-12
1992-06-09
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540491, A61K 3155, C07D28102
Patent
active
051207303
ABSTRACT:
A class of benzothiazepine esters having structures related to that of diltiazem are provided which possess vasodilating activity while being virtually free of cardiodepressive effects. The esters are useful in the treatment of arterial hypertension and disturbances of the cerebral circulation.
The compounds have the general formula I ##STR1## wherein R represents hydrogen or an electronegative group (preferably a halogen atom, or a nitro, trifluoromethyl or methoxy group); and
REFERENCES:
patent: 3562257 (1971-02-01), Kugita et al.
Merck Index, 11th edition, 1989, Merce & Co., Rahway, N.J., p. 505, item 3188.
Joslyn et al., J. Med. Chem., vol. 31, pp. 1489-1492 (1988).
Malandrino Salvatore
Nizzola Rita
Pifferi Giorgio
Bond Robert T.
IdB Holding SpA
LandOfFree
Benzothiazepine esters, their preparation and formulations for t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzothiazepine esters, their preparation and formulations for t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiazepine esters, their preparation and formulations for t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1804660